Skip to main content
. 2014 Jul 31;5(17):7748–7759. doi: 10.18632/oncotarget.2294

Table 2. Cox proportional analysis for the prediction of CRPC progression-free survival.

Covariant HR 95% CI P-value
miR-27b 0.255 0.069-0.944 0.0407
Gleason score 2.003 0.747-5.374 0.1674
cT stage 2.111 0.490-9.098 0.3162
cN stage 2.28 0.372-13.975 0.3729
cM stage 1.021 0.203-5.124 0.9799
PSA 1.001 1.000-1.001 0.0719
Age 1.045 0.949-1.150 0.3674